Zobrazeno 101 - 110
of 538
pro vyhledávání: '"Monika Engelhardt"'
Autor:
Alina Müller-Rudorf, Robert Zeiser, Chuanjiang Yu, Tobias B. Huber, Lena J. Lippert, Marie Follo, Stefanie Kreutmair, Monika Engelhardt, Sivahari P. Gorantla, Anna Lena Illert, Lena Jakob, Tony Andreas Müller, Corinna Albers, Justus Duyster, Zhenyu Yue
Publikováno v:
Haematologica
Autophagy is a genetically regulated process of adaptation to metabolic stress and was recently shown to be involved in the treatment response of chronic myeloid leukemia (CML). However, in vivo data are limited and the molecular mechanism of autopha
Publikováno v:
Biometrical Journal. 62:822-835
Prognosis is usually expressed in terms of the probability that a patient will or will not have experienced an event of interest t years after diagnosis of a disease. This quantity, however, is of little informative value for a patient who is still e
Autor:
Stefan Wöhrl, Stefanie Ajayi, Markus Ruch, Martin J. Hug, Petra Otte, Heike Reinhardt, Monika Engelhardt, Alison G. Eggleton, Justus Duyster, Manfred Jung
Publikováno v:
Cancer. 125:1547-1557
Background At Freiburg University Medical Center, chemotherapy prescriptions are processed via a computerized physician order entry (CPOE) tool and clinically checked by a designated chemotherapy surveillance team. Any error detected is reported inst
Autor:
Christine Greil, Monika Engelhardt, Reinhard Marks, Ralph Wäsch, Hermann Einsele, Hartmut Bertz, Robert Zeiser, Gabriele Ihorst, Justus Duyster, Katja Schoeller, Jürgen Finke
Publikováno v:
Haematologica
Despite significantly improved survival and response rates in patients diagnosed with multiple myeloma, it still remains an incurable disease with a poor outcome, especially in high-risk groups. Allogeneic stem cell transplantation offers a potential
Autor:
Monika Engelhardt, Achim Rieth, Andrea Lebioda, Sebastian Gonzalez-McQuire, Martina Schoehl, Moushmi Singh, Tilman Hans Steinmetz, Leah Fink
Publikováno v:
Journal of medical economics. 24(1)
To assess the real-world healthcare resource utilization (HRU) and costs associated with different proteasome inhibitors (PIs) for the treatment of patients with relapsed and/or refractory multiple myeloma (RRMM) in Germany. We conducted a retrospect
Autor:
Mario Boccadoro, Peter Leif Bergsagel, Noopur Raje, Xavier Leleu, Cristina João, Joseph R. Mikhael, Monika Engelhardt, Brian G.M. Durie, Sarah A. Holstein, Heinz Ludwig, Parameswaran Hari, Gordon Cook, Anders Waage, Maria-Victoria Mateos, Ulf-Henrik Mellqvist, Hareth Nahi, Faith E. Davies, Jian Hou, Angelo Maiolino, Saad Z. Usmani, Nizar J. Bahlis, Wee Joo Chng, Sigurdur Y. Kristinsson, Fernando Leal da Costa, Hartmut Goldschmidt, Evangelos Terpos, Pieter Sonneveld, Dominik Dytfeld, Artur Jurczyszyn, Michele Cavo, Fredrik Schjesvold, Meletios A. Dimopoulos, Jacob P. Laubach, Jesus San Miguel, Kwee Yong, Elena Zamagni, Orhan Sezer, Martin Kaiser, Surbhi Sidana, Vania Hungria, Meral Beksac, Enrique M. Ocio, Nikhil C. Munshi, Kenneth C. Anderson, Katja Weisel, Thierry Facon, Annette Juul Vangsted, Christoph Driessen, Hermann Einsele, Luciano J. Costa, Shaji Kumar, Paul G. Richardson, Philippe Moreau, Jesus G. Berdeja, Roman Hájek, Thomas G. Martin, Sagar Lonial, David H. Vesole, Rafael Fonseca, Suzanne Lentzsch, Eloisa Riva, Simon J. Harrison, Hang Quach, Rachid Baz, S. Vincent Rajkumar, Niels W.C.J. van de Donk, Joan Bladé, Jean-Luc Harousseau, Sonja Zweegman
Publikováno v:
Moreau, P, Kumar, S K, San Miguel, J, Davies, F, Zamagni, E, Bahlis, N, Ludwig, H, Mikhael, J, Terpos, E, Schjesvold, F, Martin, T, Yong, K, Durie, B G M, Facon, T, Jurczyszyn, A, Sidana, S, Raje, N, van de Donk, N, Lonial, S, Cavo, M, Kristinsson, S Y, Lentzsch, S, Hajek, R, Anderson, K C, João, C, Einsele, H, Sonneveld, P, Engelhardt, M, Fonseca, R, Vangsted, A, Weisel, K, Baz, R, Hungria, V, Berdeja, J G, Leal da Costa, F, Maiolino, A, Waage, A, Vesole, D H, Ocio, E M, Quach, H, Driessen, C, Bladé, J, Leleu, X, Riva, E, Bergsagel, P L, Hou, J, Chng, W J, Mellqvist, U H, Dytfeld, D, Harousseau, J L, Goldschmidt, H, Laubach, J, Munshi, N C, Gay, F, Beksac, M, Costa, L J, Kaiser, M, Hari, P, Boccadoro, M, Usmani, S Z, Zweegman, S, Holstein, S, Sezer, O, Harrison, S, Nahi, H, Cook, G, Mateos, M V, Rajkumar, S V, Dimopoulos, M A & Richardson, P G 2021, ' Treatment of relapsed and refractory multiple myeloma : recommendations from the International Myeloma Working Group ', The Lancet Oncology, vol. 22, no. 3, pp. e105-e118 . https://doi.org/10.1016/S1470-2045(20)30756-7
The Lancet Oncology, 22(3), e105-e118. Lancet Publishing Group
The Lancet Oncology, 22(3), e105-e118. Lancet Publishing Group
This Policy Review presents the International Myeloma Working Group's clinical practice recommendations for the treatment of relapsed and refractory multiple myeloma. Based on the results of phase 2 and phase 3 trials, these recommendations are propo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c99da86a5d6bbf2b40b4b619992f7c0
http://hdl.handle.net/2318/1791005
http://hdl.handle.net/2318/1791005
Autor:
Depenbusch R, Monika Engelhardt, G Illerhaus, A Salar, Hartmut Link, M Zaiss, Uwe M. Martens, Andreas Lammerich, A Köhler, Anton Buchner, S. Mahlmann, Peter Bias
Publikováno v:
Supportive Care in Cancer
Abstract Background Lipegfilgrastim has been shown to be non-inferior to pegfilgrastim for reduction of the duration of severe neutropenia (DSN) in breast cancer patients. This open-label, non-inferiority study assessed the efficacy and safety of lip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a8657188cc8b2101ff28372bdb39918
http://hdl.handle.net/10230/52526
http://hdl.handle.net/10230/52526
Autor:
Francesca Gay, Andreas Günther, Massimo Offidani, Monika Engelhardt, Marco Salvini, Vittorio Montefusco, Francesca Patriarca, Sara Aquino, Wolfram Pönisch, Stefano Spada, Natalie Schub, Silvia Gentili, Ralph Wäsch, Paolo Corradini, Christian Straka, Antonio Palumbo, Hermann Einsele, Mario Boccadoro, Pieter Sonneveld, Martin Gramatzki
Background Combined therapy with carfilzomib, bendamustine, and dexamethasone was evaluated in this multicenter phase 1/2 trial conducted within the European Myeloma Network (EMN09 trial). Methods Sixty-three patients with relapsed/refractory multipl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199b6ee92592912e8089dfcbb8d06e37
http://hdl.handle.net/2318/1804019
http://hdl.handle.net/2318/1804019
Autor:
Heinz Ludwig, Mario Boccadoro, Philippe Moreau, Jesus San-Miguel, Michele Cavo, Charlotte Pawlyn, Sonja Zweegman, Thierry Facon, Christoph Driessen, Roman Hajek, Melitios A. Dimopoulos, Francesca Gay, Hervé Avet-Loiseau, Evangelos Terpos, Niklas Zojer, Mohamad Mohty, Maria-Victoria Mateos, Hermann Einsele, Michel Delforge, Jo Caers, Katja Weisel, Graham Jackson, Laurent Garderet, Monika Engelhardt, Niels van de Donk, Xavier Leleu, Hartmut Goldschmidt, Meral Beksac, Inger Nijhof, Niels Abildgaard, Sara Bringhen, Pieter Sonneveld
Publikováno v:
Ludwig, H, Boccadoro, M, Moreau, P, San-Miguel, J, Cavo, M, Pawlyn, C, Zweegman, S, Facon, T, Driessen, C, Hajek, R, Dimopoulos, M A, Gay, F, Avet-Loiseau, H, Terpos, E, Zojer, N, Mohty, M, Mateos, M V, Einsele, H, Delforge, M, Caers, J, Weisel, K, Jackson, G, Garderet, L, Engelhardt, M, van de Donk, N, Leleu, X, Goldschmidt, H, Beksac, M, Nijhof, I, Abildgaard, N, Bringhen, S & Sonneveld, P 2021, ' Recommendations for vaccination in multiple myeloma : a consensus of the European Myeloma Network ', Leukemia, vol. 35, no. 1, pp. 31–44 . https://doi.org/10.1038/s41375-020-01016-0
Leukemia
Ludwig, H, Boccadoro, M, Moreau, P, San-Miguel, J, Cavo, M, Pawlyn, C, Zweegman, S, Facon, T, Driessen, C, Hajek, R, Dimopoulos, M A, Gay, F, Avet-Loiseau, H, Terpos, E, Zojer, N, Mohty, M, Mateos, M V, Einsele, H, Delforge, M, Caers, J, Weisel, K, Jackson, G, Garderet, L, Engelhardt, M, van de Donk, N, Leleu, X, Goldschmidt, H, Beksac, M, Nijhof, I, Abildgaard, N, Bringhen, S & Sonneveld, P 2021, ' Recommendations for vaccination in multiple myeloma : a consensus of the European Myeloma Network ', Leukemia, vol. 35, no. 1, pp. 31-44 . https://doi.org/10.1038/s41375-020-01016-0
Leukemia
Ludwig, H, Boccadoro, M, Moreau, P, San-Miguel, J, Cavo, M, Pawlyn, C, Zweegman, S, Facon, T, Driessen, C, Hajek, R, Dimopoulos, M A, Gay, F, Avet-Loiseau, H, Terpos, E, Zojer, N, Mohty, M, Mateos, M V, Einsele, H, Delforge, M, Caers, J, Weisel, K, Jackson, G, Garderet, L, Engelhardt, M, van de Donk, N, Leleu, X, Goldschmidt, H, Beksac, M, Nijhof, I, Abildgaard, N, Bringhen, S & Sonneveld, P 2021, ' Recommendations for vaccination in multiple myeloma : a consensus of the European Myeloma Network ', Leukemia, vol. 35, no. 1, pp. 31-44 . https://doi.org/10.1038/s41375-020-01016-0
Vaccination is one of the most successful medical interventions that has saved the life of millions of people. Vaccination is particularly important in patients with multiple myeloma, who have an increased risk of infections due to the disease-inhere
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1c52aa5bff908d97a47f03d6348e874
http://hdl.handle.net/2318/1769114
http://hdl.handle.net/2318/1769114
Autor:
Laura Rosiñol, Meral Beksac, Elena Zamagni, Niels W. C. J. Van de Donk, Kenneth C. Anderson, Ashraf Badros, Jo Caers, Michele Cavo, Meletios‐Athanasios Dimopoulos, Angela Dispenzieri, Hermann Einsele, Monika Engelhardt, Carlos Fernández de Larrea, Gösta Gahrton, Francesca Gay, Roman Hájek, Vania Hungria, Artur Jurczyszyn, Nicolaus Kröger, Robert A. Kyle, Fernando Leal da Costa, Xavier Leleu, Suzanne Lentzsch, Maria V. Mateos, Giampaolo Merlini, Mohamad Mohty, Philippe Moreau, Leo Rasche, Donna Reece, Orhan Sezer, Pieter Sonneveld, Saad Z. Usmani, Karin Vanderkerken, David H. Vesole, Anders Waage, Sonja Zweegman, Paul G. Richardson, Joan Bladé
Publikováno v:
Rosiñol, L, Beksac, M, Zamagni, E, Van de Donk, N W C J, Anderson, K C, Badros, A, Caers, J, Cavo, M, Dimopoulos, M A, Dispenzieri, A, Einsele, H, Engelhardt, M, Fernández de Larrea, C, Gahrton, G, Gay, F, Hájek, R, Hungria, V, Jurczyszyn, A, Kröger, N, Kyle, R A, Leal da Costa, F, Leleu, X, Lentzsch, S, Mateos, M V, Merlini, G, Mohty, M, Moreau, P, Rasche, L, Reece, D, Sezer, O, Sonneveld, P, Usmani, S Z, Vanderkerken, K, Vesole, D H, Waage, A, Zweegman, S, Richardson, P G & Bladé, J 2021, ' Expert review on soft-tissue plasmacytomas in multiple myeloma : definition, disease assessment and treatment considerations ', British Journal of Haematology, vol. 194, no. 3, pp. 496-507 . https://doi.org/10.1111/bjh.17338
In this review, two types of soft-tissue involvement in multiple myeloma are defined: (i) extramedullary (EMD) with haematogenous spread involving only soft tissues and (ii) paraskeletal (PS) with tumour masses arising from skeletal lesions. The inci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::808c0e8196dcdf4a4756120a00827be9
http://hdl.handle.net/11585/865197
http://hdl.handle.net/11585/865197